-
DAVI share price: currently unavailable. Sorry, we currently don't have enough data to create an insight.
-
Price change
The price of DAVI shares has increased $0.28 since the market last closed. This is a 21.37% rise.
-
Closed at $1.59.
The stock has remained unchanged in after-hours trading.
Key terms
About DAVI
Davion Healthcare Plc engages in the development of home test products for potential medical conditions to provide early warning to enable further clinical examinations. It offers non-invasive home test products such as it's BreastCheck for breast abnormalities. The company was founded on November 29, 2022 and is headquartered in Cork, Ireland.
-
Market cap: $39.75M
A market capitalization up to $300 million places DAVI in the micro-capitalization category.
Key terms
Smart score
Latest DAVI news
No recent TipRanks articles are available for DAVI
DAVI Financials
-
DAVI total revenue: temporarily unavailable. We are sorry, but this information is temporarily unavailable.
-
DAVI net income: temporarily unavailable. We are sorry, but this information is temporarily unavailable.
-
DAVI earnings per share: temporarily unavailable. We are sorry, but this information is temporarily unavailable.
Key terms
DAVI Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
DAVI Competitors
-
How competitors are chosen
DAVI's competitors are included in the Health Technology sector and Medical Specialties group
-
Market cap: $39.75M
A market capitalization up to $300 million places DAVI in the micro-capitalization category.
